Links

Tools

Export citation

Search in Google Scholar

Efficacy and Safety of Switching to Tenofovir Alafenamide (Taf) in Virally Suppressed Chronic Hepatitis B (Chb) Patients With Renal Impairment: Week 24 Results From a Phase 2 Open-Label Study

Journal article published in 2019 by Harry L. A. Janssen, Young-Suk Lim, Edward J. Gane, Claire Fournier, Sang Hoon Ahn, Owen Tsang, Wan Long Chuang, Jeong Heo, Aric Josun Hui, Magdy Elkhashab, Chi-Yi Chen, Wei-Wen Su, John F. Flaherty, Anuj Gaggar, Susanna Tan and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload